ConductScience.org, home

Paper37520195

In vitro evaluation of herbal based Lesh Nat B cream against Leishmania tropica.

Gul S and 7 others. J Parasit Dis, 2023. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. In vitro evaluation of herbal based Lesh Nat B cream against Leishmania tropica. Papers, record 37520195. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37520195

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro evaluation of herbal based Lesh Nat B cream against Leishmania tropica.
PubMed
Journal
J Parasit Dis
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2024-09-02
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gul SSahiba
2Khan MMomin
3Amin AAdnan
4Zaman AAli
5Said AArsalan
6Iqbal AAamir
7Muhammad SSher
8Khan RURahat Ullahhttps://orcid.org/0000-0002-7109-6201

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110395884Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.J Infect Dis1999https://conductscience.org/library/papers/10395884PubMed
230484256Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.Drug Deliv Transl Res2019https://conductscience.org/library/papers/30484256PubMed
322575984Leishmaniasis: current status of available drugs and new potential drug targets.Asian Pac J Trop Med2012https://conductscience.org/library/papers/22575984PubMed
419889134Cutaneous and mucocutaneous leishmaniasis.Dermatol Ther2009https://conductscience.org/library/papers/19889134PubMed
535692473In vitro efficacy of polymer coated miltefosine drug against leishmania tropica.J Parasit Dis2022https://conductscience.org/library/papers/35692473PubMed
622764295Consecutive cutaneous and visceral leishmaniasis manifestations involving a novel Leishmania species in two HIV patients in Thailand.Am J Trop Med Hyg2012https://conductscience.org/library/papers/22764295PubMed
725540961Evaluation of antileishmanial activity and cytotoxicity of the extracts of Berberis vulgaris and Nigella sativa against Leishmania tropica.J Vector Borne Dis2014https://conductscience.org/library/papers/25540961PubMed
830166789Preparation of meglumine antimonate loaded albumin nanoparticles and evaluation of its anti-leishmanial activity: an in vitro assay.J Parasit Dis2018https://conductscience.org/library/papers/30166789PubMed
98586751A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution.J Dermatol1995https://conductscience.org/library/papers/8586751PubMed
1028476600Epidemic outbreak of anthroponotic cutaneous leishmaniasis in Kohat District, Khyber Pakhtunkhwa, Pakistan.Acta Trop2017https://conductscience.org/library/papers/28476600PubMed
1131263321Leishmanicidal effects of amphotericin B in combination with selenium loaded on niosome against Leishmania tropica.J Parasit Dis2019https://conductscience.org/library/papers/31263321PubMed
1232411255Quinine Sulphate Microparticles as Treatment for Leishmaniasis.J Trop Med2020https://conductscience.org/library/papers/32411255PubMed
1322360481Leishmaniasis: prevention, parasite detection and treatment.Curr Med Chem2012https://conductscience.org/library/papers/22360481PubMed
1437193496The in vitro and in vivo effects of Lucilia sericata larval secretions on Leishmania major.J Parasit Dis2023https://conductscience.org/library/papers/37193496PubMed
1511820764Plant natural products with leishmanicidal activity.Nat Prod Rep2001https://conductscience.org/library/papers/11820764PubMed
1611260171Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis.Clin Exp Dermatol2001https://conductscience.org/library/papers/11260171PubMed
1729260674Epidemiology of Cutaneous Leishmaniasis Outbreak, Waziristan, Pakistan.Emerg Infect Dis2018https://conductscience.org/library/papers/29260674PubMed
1835888346Investigation of Cytotoxicity of Biosynthesized Colloidal Nanosilver against Local Leishmania tropica: In Vitro Study.Materials (Basel)2022https://conductscience.org/library/papers/35888346PubMed
1922693548Leishmaniasis worldwide and global estimates of its incidence.PLoS One2012https://conductscience.org/library/papers/22693548PubMed
2018958168Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan.PLoS Negl Trop Dis2008https://conductscience.org/library/papers/18958168PubMed

See all 25 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37520195

GET https://conductscience.org/api/papers/v1/37520195/references?page=2